eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2022
vol. 24
 
Share:
Send email
Share:
Original paper

Evaluation of the effectiveness of a mobile application on the adherence of patients with atrial fibrillation

GANI TULEPBERGENOV
1
,
DINARA OSPANOVA
2
,
SAIRA ALIMBAYEVA
1
,
ARAS PUODZIUKYNAS
3
,
ALMAT KODASBAYEV
1
,
ALIYA ABENOVA
1
,
AIZHAN ALMUKHANOVA
1
,
SHYNAR TANABAYEVA
1
,
ILDAR FAKHRADIYEV
1
,
ALTYNAY SADYKOVA
4

  1. S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  2. Al-Farabi Kazakh National University, Almaty, Kazakhstan
  3. Lithuanian University of Health Sciences, Kaunas, Lithuania
  4. Scientific Centre of Paediatrics and Children’s Surgery, Almaty, Kazakhstan
Family Medicine & Primary Care Review 2022; 24(3): 275–283
DOI: https://doi.org/10.5114/fmpcr.2022.118289
Online publish date: 2022/10/03
Article file
- 15 FM&PCR 3 22 - O - Tulepbergenov - Evaluation - 1147.pdf  [0.55 MB]
Get citation
 
PlumX metrics:
 
1. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012; 157(11): 785–795, doi: 10.7326/0003-4819-157-11-201212040-00538.
2. Bolevich S, Draginic N, Andjic M, et al. The Effects of DPP4 Inhibitors on Lipid Status and Blood Pressure in Rats with Diabetes Mellitus Type 2. Serbian Journal of Experimental and Clinical Research 2019; 20, doi: 10.2478/sjecr-2019-0037.
3. Bowry AD, Shrank WH, Lee JL, et al. A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med 2011; 26(12): 1479–1491, doi: 10.1007/s11606-011-1825-3.
4. Kvarnström K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ Open 2018; 8(1): e015332, doi: 10.1136/bmjopen-2016-015332.
5. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol 2014; 11(11): 639–654, doi: 10.1038/nrcardio.2014.118.
6. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129(8): 837–847, doi: 10.1161/circulationaha.113.005119.
7. Mozaffarian D, Benjamin EJ, Go AS, et al. Executive Summary: Heart Disease and Stroke Statistics – 2016 Update. Circulation 2016; 133(4): 447–454, doi: 10.1161/CIR.0000000000000366.
8. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016; 50(5): e1–e88, doi: 10.1093/ejcts/ezw313.
9. Lip G, Freedman B, De Caterina R, et al. Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making. Thromb Haemost 2017; 117(7): 1230–1239, doi: 10.1160/th16-11-0876.
10. American Heart Association. What is Atrial Fibrillation (AFib or AF)? American Heart Association 2016 [cited 02.02.2022]. Available from URL: http://www.heart.org/en/health-topics/atrial-fibrillation/what-is-atrial-fibrillation-afib-or-af.
11. Reading SR, Black MH, Singer DE, et al. Risk factors for medication non-adherence among atrial fibrillation patients. BMC Cardiovasc Disord 2019; 19(1): 38, doi: 10.1186/s12872-019-1019-1.
12. Andjelkovic M, Mitrovic M, Nikolic I, et al. Older Hypertensive Patients′ Adherence to Healthy Lifestyle Behaviors. Serbian Journal of Experimental and Clinical Research 2016; 19, doi: 10.1515/sjecr-2016-0083.
13. Cransac-Miet A, Zeller M, Chagué F, et al. Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: towards a time bomb. Int J Cardiol 2021; 323: 285–287, doi: 10.1016/j.ijcard.2020.08.094.
14. Palmer K, Monaco A, Kivipelto M, et al. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res 2020; 32(7): 1189–1194, doi: 10.1007/s40520-020-01601-4.
15. Senbekov M, Saliev T, Bukeyeva Z, et al. The Recent Progress and Applications of Digital Technologies in Healthcare: A Review. Int J Telemed Appl 2020; 2020: 8830200, doi: 10.1155/2020/8830200.
16. Hickey KT, Riga TC, Mitha SA, et al. Detection and management of atrial fibrillation using remote monitoring. Nurs Pract 2018; 43(3): 24–30, doi: 10.1097/01.NPR.0000530214.17031.45.
17. Guo Y, Chen Y, Lane DA, et al. Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. Am J Med 2017; 130(12): 1388–1396.e6, doi: 10.1016/j.amjmed.2017.07.003.
18. Ahmed I, Ahmad NS, Ali S, et al. Medication Adherence Apps: Review and Content Analysis. JMIR Mhealth Uhealth 2018; 6(3): e62, doi: 10.2196/mhealth.6432.
19. Hamine S, Gerth-Guyette E, Faulx D, et al. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res 2015; 17(2): e52, doi: 10.2196/jmir.3951.
20. Castellucci LA, Shaw J, Salm K van der, et al. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thromb Res 2015; 136(4): 727–731, doi: 10.1016/j.thromres.2015.07.007.
21. Obamiro KO, Chalmers L, Lee K, et al. Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey. J Cardiovasc Pharmacol Ther 2018; 23(4): 337–343, doi: 10.1177/1074248418770201.
22. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152(11): 726–732, doi: 10.7326/0003-4819-152-11-201006010-00232.
23. Eysenbach G, Group C-E. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res 2011; 13(4): e126, doi: 10.2196/jmir.1923.
24. Lévy S, Camm AJ, Saksena S, et al. International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2003; 14(4): 443–445, doi: 10.1046/j.1540-8167.2003.00003.x.
25. Population census in Kazakhstan. 2009 [cited 03.01.2022]. Available from URL: https://stat.gov.kz/.
26. Bou Serhal R, Salameh P, Wakim N, et al. A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults. Int J Hypertens 2018; 2018: 3934296, doi: 10.1155/2018/3934296.
27. El-Hajj M, Ajrouche R, Zein S, et al. Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation. Pharm Pract 2020; 18(2): 1860, doi: 10.18549/PharmPract.2020.2.1860.
28. Van Huy N, Thu NTH, Anh NLT, et al. The validation of organisational culture assessment instrument in healthcare setting: results from a cross-sectional study in Vietnam. BMC Public Health 2020; 20(1): 316, doi: 10.1186/s12889-020-8372-y.
29. Republican Center for Health Development. Clinical protocol for diagnosis and treatment of the Ministry of Healthсаre of the Republic of Kazakhstan “Atrial fibrillation and flutter” No. 105 dated July 30, 2020 [cited 23.02.2022]. Available from URL: http://www.rcrz.kz/index.php/en/.
30. Carmody JK, Denson LA, Hommel KA. Content and Usability Evaluation of Medication Adherence Mobile Applications for Use in Pediatrics. J Pediatr Psychol 2019; 44(3): 333–342, doi: 10.1093/jpepsy/jsy086.
31. Serrano Afonso AA, Pérez Hernández C, Ochoa Mazarro D, et al. Association between chronic pain medications and the severity and mortality of COVID-19: Study protocol for a case-population study. Medicine (Baltimore) 2021; 100(30): e26725, doi: 10.1097/md.0000000000026725.
32. Imai K, Jiang Z. A sensitivity analysis for missing outcomes due to truncation by death under the matched-pairs design. Stat Med 2018; 37(20): 2907–2922, doi: 10.1002/sim.7802.
33. Noblet T, Marriott J, Hensman-Crook A, et al. Independent prescribing by advanced physiotherapists for patients with low back pain in primary care: a feasibility trial with an embedded qualitative component. PLoS ONE 2020; 15(3): e0229792, doi: 10.1371/journal.pone.0229792.
34. Jankowska-Polańska B, Lomper K, Alberska L, et al. Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation. J Geriatr Cardiol 2016; 13(7): 559–565, doi: 10.11909/j.issn.1671-5411.2016.07.006.
35. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285(18): 2370–2375, doi: 10.1001/jama.285.18.2370.
36. Camm AJ, Accetta G, Ambrosio G, et al. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart 2017; 103(4): 307–314, doi: 10.1136/heartjnl-2016-309832.
37. Gamra H, Murin J, Chiang CE, et al. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey. Arch Cardiovasc Dis 2014; 107(2): 77–87, doi: 10.1016/j.acvd.2014.01.001.
38. Olivia C, Hastie C, Farshid A. Adherence to guidelines regarding anticoagulation and risk factors for progression of atrial fibrillation in a nurse-led clinic. Intern Med J 2021; 51(7): 1136–1142, doi: 10.1111/imj.14874.
39. Lavie CJ, De Schutter A, Parto P, et al. Obesity and Prevalence of Cardiovascular Diseases and Prognosis – The Obesity Paradox Updated. Prog Cardiovasc Dis 2016; 58(5): 537–547, doi: 10.1016/j.pcad.2016.01.008.
40. Lavie CJ, Sharma A, Alpert MA, et al. Update on Obesity and Obesity Paradox in Heart Failure. Prog Cardiovasc Dis 2016; 58(4): 393–400, doi: 10.1016/j.pcad.2015.12.003.
41. Day E, Rudd JHF. Alcohol use disorders and the heart. Addiction 2019; 114(9): 1670–1678, doi: 10.1111/add.14703.
42. Gilmore A, Pomerleau J, McKee M, et al. Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Am J Public Health 2004; 94(12): 2177–2187, doi: 10.2105/ajph.94.12.2177.
43. Sairenchi T, Yamagishi K, Iso H, et al. Atrial Fibrillation with and without Cardiovascular Risk Factors and Stroke Mortality. J Atheroscler Thromb 2021; 28(3): 241–248, doi: 10.5551/jat.53629.
44. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146(12): 857–867, doi: 10.7326/0003-4819-146-12-200706190-00007.
45. García-Sempere A, Hurtado I, Bejarano-Quisoboni D, et al. Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study. PLoS ONE 2019; 14(2): e0211681, doi: 10.1371/journal.pone.0211681.
46. Björck F, Renlund H, Lip GY, et al. Outcomes in a Warfarin-Treated Population with Atrial Fibrillation. JAMA Cardiol 2016; 1(2): 172–180, doi: 10.1001/jamacardio.2016.0199.
47. Brown MT, Bussell J, Dutta S, et al. Medication Adherence: Truth and Consequences. Am J Med Sci 2016; 351(4): 387–399, doi: 10.1016/j.amjms.2016.01.010.
48. Chen LY, Norby FL, Gottesman RF, et al. Association of Atrial Fibrillation with Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study). J Am Heart Assoc 2018; 7(6), doi: 10.1161/jaha.117.007301.
49. Fallah M, Yasini M. A Medication Reminder Mobile App: Does It Work for Different Age Ranges. Stud Health Technol Inform 2017; 235: 68–72.
50. Turchioe MR, Jimenez V, Isaac S, et al. Review of mobile applications for the detection and management of atrial fibrillation. Heart Rhythm O2 2020; 1(1): 35–43, doi: 10.1016/j.hroo.2020.02.005.
51. Lopez Perales CR, Van Spall HGC, et al. Mobile health applications for the detection of atrial fibrillation: a systematic review. Europace 2021; 23(1): 11–28, doi: 10.1093/europace/euaa139.
52. O’Sullivan JW, Grigg S, Crawford W, et al. Accuracy of Smartphone Camera Applications for Detecting Atrial Fibrillation: A Systematic Review and Meta-analysis. JAMA Netw Open 2020; 3(4): e202064, doi: 10.1001/jamanetworkopen.2020.2064.
53. Ayyaswami V, Padmanabhan DL, Crihalmeanu T, et al. Mobile health applications for atrial fibrillation: A readability and quality assessment. Int J Cardiol 2019; 293: 288–293, doi: 10.1016/j.ijcard.2019.07.026.
54. Bumpus S, Krallman R, McMahon C, et al. Insights into hospital readmission patterns of atrial fibrillation patients. Eur J Cardiovasc Nurs 2020; 19(6): 545–550, doi: 10.1177/1474515120911607.
55. Guo Y, Lane DA, Wang L, et al. Mobile Health Technology to Improve Care for Patients with Atrial Fibrillation. J Am Coll Cardiol 2020; 75(13): 1523–1534, doi: 10.1016/j.jacc.2020.01.052.
Copyright: © 2022 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.